0,879  0,004  Caspase 9 stimulant
0,882  0,007  Apoptosis agonist
0,856  0,005  TNF expression inhibitor
0,841  0,010  Antiinflammatory
0,812  0,008  Antineoplastic (breast cancer)
0,797  0,009  Antineoplastic (lung cancer)
0,771  0,003  UGT1A4 substrate
0,735  0,010  Antileukemic
0,731  0,017  Transcription factor NF kappa B inhibitor
0,708  0,006  Antineoplastic (melanoma)
0,705  0,005  Hepatic disorders treatment
0,702  0,009  Antineoplastic (ovarian cancer)
0,688  0,006  Nitric oxide antagonist
0,691  0,010  Prostate cancer treatment
0,688  0,010  Chemopreventive
0,691  0,015  Antineoplastic (colorectal cancer)
0,683  0,007  UGT1A9 substrate
0,686  0,015  Antineoplastic (colon cancer)
0,679  0,011  Chemoprotective
0,669  0,010  Sensitization
0,666  0,008  NOS2 expression inhibitor
0,648  0,005  Antineoplastic (endocrine cancer)
0,627  0,011  Antineoplastic (cervical cancer)
0,618  0,008  UGT1A6 substrate
0,619  0,009  AR expression inhibitor
0,618  0,010  Cytotoxic
0,608  0,003  UGT2B15 substrate
0,605  0,010  Antineoplastic (pancreatic cancer)
0,599  0,008  Antineoplastic (multiple myeloma)
0,593  0,005  Antihypoxic
0,580  0,005  Hepatoprotectant
0,564  0,004  UGT2B4 substrate
0,571  0,012  Caspase 3 stimulant
0,562  0,008  UGT1A1 substrate
0,559  0,010  Hypoxia-inducible factor 1 alpha inhibitor
0,557  0,012  Antineoplastic (glioma)
0,555  0,014  Apoptosis antagonist
0,558  0,018  Antipruritic, allergic
0,553  0,015  Antioxidant
0,555  0,021  Antihypercholesterolemic
0,546  0,018  CTGF expression inhibitor
0,550  0,025  Cholesterol antagonist
0,535  0,010  UDP-glucuronosyltransferase substrate
0,530  0,007  ICAM1 expression inhibitor
0,541  0,027  Aldehyde oxidase inhibitor
0,524  0,016  Antineoplastic (brain cancer)
0,545  0,039  Cyclophilin D inhibitor
0,545  0,039  Antidiabetic
0,510  0,005  Interferon gamma antagonist
0,514  0,018  NOS3 expression inhibitor
0,512  0,018  Proliferative diseases treatment
0,517  0,026  Respiratory analeptic
0,521  0,035  Antibacterial
0,512  0,030  Immunosuppressant
0,485  0,005  UGT2B7 substrate
0,489  0,016  Antipyretic
0,483  0,021  Cardiovascular analeptic
0,476  0,015  Antineoplastic (lymphoma)
0,473  0,012  Antineoplastic (liver cancer)
0,466  0,012  Antineoplastic (lymphocytic leukemia)
0,470  0,018  Antineoplastic (glioblastoma multiforme)
0,457  0,008  Contraceptive
0,462  0,018  Cardiodepressant
0,449  0,005  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,455  0,015  Vascular (periferal) disease treatment
0,462  0,026  Lipoprotein disorders treatment
0,450  0,015  Antineoplastic (renal cancer)
0,463  0,034  Bone diseases treatment
0,433  0,004  Antiinfertility, female
0,438  0,010  Abortion inducer
0,472  0,046  CYP3A4 substrate
0,452  0,029  Cardioprotectant
0,427  0,008  Antiviral (Influenza)
0,430  0,012  Antiviral (HIV)
0,427  0,010  Prostatic (benign) hyperplasia treatment
0,438  0,021  Tumour necrosis factor alpha release inhibitor
0,453  0,038  Teratogen
0,415  0,006  Antiviral (Influenza A)
0,433  0,025  Antiprotozoal (Leishmania)
0,411  0,004  Contraceptive female
0,418  0,013  Sodium/bile acid cotransporter inhibitor
0,434  0,029  Carcinogenic
0,412  0,010  Prostate disorders treatment
0,436  0,039  5 Hydroxytryptamine release stimulant
0,426  0,032  Antiosteoporotic
0,434  0,041  Antithrombotic
0,386  0,005  Cholesterol synthesis inhibitor
0,396  0,022  Antihypertriglyceridemic
0,382  0,010  Protein-tyrosine phosphatase inhibitor
0,376  0,010  Protein kinase stimulant
0,371  0,005  UGT2B9 substrate
0,404  0,042  Embryotoxic
0,382  0,025  Angiogenesis stimulant
0,396  0,039  Analeptic
0,391  0,034  Antineoplastic (non-small cell lung cancer)
0,362  0,008  Neurotrophic factor enhancer
0,365  0,014  UGT1A3 substrate
0,373  0,025  Transcription factor STAT3 inhibitor
0,355  0,007  Protein-tyrosine phosphatase 1B inhibitor
0,364  0,017  Platelet adhesion inhibitor
0,370  0,027  Transcription factor STAT inhibitor
0,356  0,013  Lipocortins synthesis antagonist
0,375  0,032  Hypoglycemic
0,372  0,030  Hypolipemic
0,342  0,003  UGT2B10 substrate
0,350  0,019  Antiviral (Herpes)
0,347  0,016  Melanin inhibitor
0,384  0,054  Immunostimulant
0,374  0,053  Antifungal
0,357  0,037  Free radical scavenger
0,321  0,005  Choleretic
0,354  0,040  DNA damaging
0,355  0,043  Antidiabetic (type 2)
0,321  0,017  Hair growth stimulant
0,322  0,018  Antineoplastic (squamous cell carcinoma)
0,306  0,009  Antifungal enhancer
0,307  0,012  Insulin secretagoues
0,312  0,017  Lipid peroxidase inhibitor
0,310  0,017  Phospholipase C inhibitor
0,366  0,075  CYP2C9 substrate
0,302  0,013  Glutathione S-transferase substrate
0,291  0,005  Aromatase inhibitor
0,295  0,009  Antihemorrhagic
0,305  0,021  Antineoplastic (carcinoma)
0,305  0,022  Antiacne
0,310  0,027  P-glycoprotein inhibitor
0,299  0,017  Liver fibrosis treatment
0,294  0,012  Antihyperlipoproteinemic
0,304  0,031  Antihelmintic
0,320  0,048  Cytostatic
0,309  0,038  Antineoplastic (sarcoma)
0,279  0,008  Androgen antagonist
0,279  0,008  Farnesoid X receptor antagonist
0,327  0,057  Interleukin 2 agonist
0,279  0,015  Antiviral (Hepatitis B)
0,298  0,034  Gastrin inhibitor
0,305  0,046  Vasodilator
0,272  0,014  DNA polymerase I inhibitor
0,300  0,043  Antiulcerative
0,268  0,015  LDLR expression enhancer
0,252  0,006  AMP-activated protein kinase stimulant
0,251  0,008  Microtubule formation inhibitor
0,287  0,047  Antiparasitic
0,246  0,006  Arachidonic acid antagonist
0,258  0,023  Monophenol monooxygenase inhibitor
0,272  0,039  RNA-directed DNA polymerase inhibitor
0,263  0,031  Antipruritic, non-allergic
0,243  0,011  UGT2B1 substrate
0,240  0,011  SULT1A1 substrate
0,243  0,015  Antineoplastic antibiotic
0,271  0,045  Antineoplastic enhancer
0,261  0,035  Antimutagenic
0,252  0,031  Antihelmintic (Nematodes)
0,244  0,024  Interleukin 6 antagonist
0,221  0,003  UGT2B11 substrate
0,228  0,013  Anticataract
0,237  0,028  Skin whitener
0,279  0,070  Renal disease treatment
0,216  0,008  Transcription factor NF kappa B stimulant
0,216  0,008  Adenylate cyclase stimulant
0,231  0,023  Interleukin 1 antagonist
0,232  0,028  Acute respiratory distress syndrome (ARDS) treatment
0,261  0,056  Antimitotic
0,297  0,095  Calcium channel activator
0,274  0,078  CYP2C19 substrate
0,294  0,100  Vasodilator, peripheral
0,195  0,009  Inducible nitric-oxide synthase inhibitor
0,191  0,005  Estradiol 17 beta-dehydrogenase inhibitor
0,202  0,017  Sulfotransferase substrate
0,190  0,005  Anabolic
0,248  0,068  DNA synthesis inhibitor
0,322  0,147  Alzheimer's disease treatment
0,175  0,003  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,179  0,008  Antiviral (SARS coronavirus)
0,179  0,008  Antiviral (Coronavirus)
0,268  0,098  Antineoplastic (osteosarcoma)
0,200  0,033  Topoisomerase II inhibitor
0,171  0,006  Androgen agonist
0,245  0,083  Interleukin agonist
0,170  0,010  CDC25A inhibitor
0,212  0,051  Antiviral (Hepatitis)
0,164  0,004  Na+ K+ transporting ATPase inhibitor
0,217  0,057  Insulin sensitizer
0,210  0,051  Diabetic nephropathy treatment
0,199  0,040  Antirickettsial
0,206  0,049  Antineoplastic (gastric cancer)
0,249  0,093  Radioprotector
0,192  0,039  Genotoxic
0,174  0,023  Pregnane X receptor agonist
0,156  0,005  Anticholelithogenic
0,156  0,009  Glutamate release inhibitor
0,154  0,007  Bile acid receptor antagonist
0,150  0,003  Heme oxygenase stimulant
0,147  0,004  RNA-directed RNA polymerase stimulant
0,152  0,012  Antiviral (Rhinovirus)
0,147  0,008  Glycine receptor antagonist
0,153  0,014  Paget's disease treatment
0,206  0,071  Anesthetic general
0,163  0,030  Endometrios treatment
0,143  0,013  HIV-1 integrase (Strand Transfer) inhibitor
0,145  0,016  Contraceptive male
0,173  0,045  SULT1A3 substrate
0,181  0,053  Diuretic
0,228  0,101  Antineoplastic (bladder cancer)
0,132  0,007  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,182  0,058  Antineoplastic (bone cancer)
0,162  0,038  Cyclooxygenase 3 inhibitor
0,173  0,050  Anesthetic
0,155  0,033  Ca2+-transporting ATPase inhibitor
0,146  0,025  Estrogen antagonist
0,181  0,060  Toxic, respiratory center
0,137  0,020  SULT1E1 substrate
0,136  0,025  Actinic keratosis treatment
0,147  0,036  Expectorant
0,187  0,077  Wound healing agent
0,230  0,122  Metabolic disease treatment
0,115  0,009  5-Alpha-reductase inhibitor
0,148  0,042  Growth stimulant
0,127  0,024  Lanosterol 14 alpha demethylase inhibitor
0,117  0,014  Estrogen agonist
0,125  0,023  Ornithine decarboxylase inhibitor
0,154  0,052  Acetylcholinesterase inhibitor
0,102  0,005  Acetyl-CoA transferase 2 inhibitor
0,202  0,106  Myocardial infarction treatment
0,255  0,159  Antiprotozoal
0,104  0,011  Antimycoplasmal
0,155  0,062  Amylase inhibitor
0,121  0,030  ABCA1 expression enhancer
0,099  0,008  Aldosterone antagonist
0,109  0,019  SULT1A2 substrate
0,195  0,111  Antidiabetic symptomatic
0,118  0,035  Estrogen receptor beta antagonist
0,115  0,032  Topoisomerase II alpha inhibitor
0,100  0,017  Postmenopausal disorders treatment
0,158  0,078  Antiviral (Hepatitis C)
0,131  0,050  Topoisomerase I inhibitor
0,105  0,024  Estrogen receptor alpha antagonist
0,093  0,013  SULT2A1 substrate
0,104  0,025  Histone deacetylase stimulant
0,104  0,025  Histone deacetylase SIRT1 stimulant
0,088  0,009  Lipocortins synthesis agonist
0,121  0,044  Antineoplastic, alkylator
0,149  0,073  Antidiarrheal
0,082  0,007  Adenylate cyclase 1 inhibitor
0,132  0,058  Coagulant
0,077  0,005  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,083  0,012  Postcoital contraceptive
0,095  0,024  Glycine receptor agonist
0,139  0,068  Psychosexual dysfunction treatment
0,126  0,056  Alcohol dehydrogenase substrate
0,075  0,006  Farnesoid X receptor agonist
0,262  0,193  Calcium channel L-type activator
0,119  0,050  HDL-cholesterol increasing
0,084  0,016  Phosphorylase inhibitor
0,241  0,174  Atherosclerosis treatment
0,088  0,022  CDC25B inhibitor
0,219  0,153  GST M1-1 substrate
0,069  0,004  Tubulin agonist
0,077  0,013  Potassium channel Kv1.3 blocker
0,082  0,020  Acetyl-CoA transferase inhibitor
0,096  0,033  Thioredoxin reductase inhibitor
0,078  0,017  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,143  0,082  Cholinergic
0,108  0,048  DNA directed RNA polymerase inhibitor
0,075  0,015  Estrogen receptor beta agonist
0,097  0,037  3C-Like protease (SARS coronavirus) inhibitor
0,108  0,048  Prolactin inhibitor
0,063  0,006  Glucose-6-phosphate dehydrogenase inhibitor
0,185  0,129  Antihypotensive
0,090  0,034  Narcotic antagonist
0,122  0,066  Alkylator
0,064  0,010  Microtubule stabilization
0,058  0,006  Estrone sulfatase inhibitor
0,062  0,010  Parathyroid hormone antagonist
0,078  0,033  Hyperparathyroidism treatment
0,167  0,122  VEGF expression inhibitor
0,086  0,042  Antibiotic
0,127  0,083  CC chemokine 6 receptor antagonist
0,107  0,063  Antiprotozoal (Toxoplasma)
0,134  0,092  NOS3 expression enhancer
0,055  0,013  Glucocorticoid antagonist
0,052  0,010  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,113  0,073  Adenylate cyclase inhibitor
0,114  0,073  Beta amyloid protein antagonist
0,151  0,111  Septic shock treatment
0,146  0,108  ATPase inhibitor
0,115  0,078  Antiseptic
0,045  0,009  Cholesterol ester transfer protein antagonist
0,196  0,160  CYP1A2 substrate
0,050  0,017  Hypogonadism treatment
0,099  0,066  Protease inhibitor
0,080  0,049  Keratolytic
0,033  0,003  Telomerase stimulant
0,036  0,008  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,189  0,161  Antimycobacterial
0,095  0,068  Nitric-oxide synthase inhibitor
0,053  0,026  Cholesterol esterase inhibitor
0,034  0,007  Hedgehog signaling activator
0,105  0,079  Antitussive
0,033  0,008  Dopamine D1 agonist
0,040  0,015  HMG CoA reductase inhibitor
0,029  0,007  Corticosteroid-like
0,124  0,102  Mutagenic
0,158  0,137  Antiamyloidogenic
0,031  0,011  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,057  0,038  Pregnane X receptor antagonist
0,062  0,045  Nitric oxide donor
0,062  0,045  HIV-1 integrase (3'-Processing) inhibitor
0,141  0,124  Psychostimulant
0,206  0,189  FMO1 substrate
0,116  0,099  Vanilloid 1 agonist
0,042  0,025  Cholesterol absorption inhibitor
0,172  0,156  Antituberculosic
0,057  0,042  Botulinum neurotoxin type A inhibitor
0,081  0,065  Estrogen-related receptor beta agonist
0,110  0,094  Retinoprotector
0,037  0,022  Estrogen receptor alpha agonist
0,085  0,071  Thioredoxin inhibitor
0,150  0,137  Antiparkinsonian, rigidity relieving
0,124  0,111  Phospholipase A2 inhibitor
0,139  0,126  Interleukin antagonist
0,024  0,012  Vitamin D receptor antagonist
0,064  0,052  Potassium channel large-conductance Ca-activated activator
0,017  0,007  Antibiotic Tetracycline-like
0,067  0,057  Lipase inhibitor
0,049  0,041  Anesthetic inhalation
0,019  0,011  Progesterone agonist
0,017  0,010  Vitamin D receptor agonist
0,060  0,054  Prolactin release inhibitor
0,030  0,025  ATP citrate lysase inhibitor
0,008  0,003  Transcortin receptor antagonist
0,014  0,009  Glucocorticoid agonist
0,064  0,060  HIV-1 integrase inhibitor
0,129  0,125  Antipruritic
0,100  0,097  Antiviral (CMV)
0,018  0,016  5-Alpha-reductase 2 inhibitor
0,030  0,029  Progesterone antagonist
0,011  0,011  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor

